In addition to dopamine and its metabolite reduction, dopamine receptor decline [61,139] may also contribute to AD pathogenesis, partly due to select DRD1 B2 and DRD3 1 allele polymorphism [140]. This evidence concerns the gene DRD1 and Alzheimer disease.